Diagnostics & Imaging
Tempus ECG-PH
AI software that analyzes standard 12-lead ECGs for signs associated with pulmonary hypertension.
The Signal
FDA 510(k) cleared in August 2026 (K253699) as Tempus' third cleared cardiovascular AI product, flagging elevated pulmonary artery pressure before invasive right-heart catheterization.
More in Diagnostics & Imaging
Aidoc
AI-driven triage and notification software for detecting acute abnormalities in medical imaging scans.
View toolViz.ai
Care coordination platform using artificial intelligence to identify strokes and other vascular diseases.
View toolLunit INSIGHT
AI-powered radiology solutions for detecting lung abnormalities and breast cancer on chest X-rays.
View toolPaige AI
FDA-cleared digital pathology software utilizing artificial intelligence to assist pathologists in cancer detection.
View tooliRhythm Zio
Ambulatory cardiac monitoring service using wearable biosensors and cloud-based data analytics.
View toolPathAI
AI-powered pathology analysis tools for drug development and diagnostic accuracy in clinical trials.
View tool